CAS 1661839-45-7

Fórmula: C23H24ClN5O

InChI: InChI=1S/C23H24ClN5O/c1-28-15-18(12-27-28)16-2-4-17(5-3-16)19-13-25-14-20(24)21(19)29-10-7-23(8-11-29)6-9-26-22(23)30/h2-5,12-15H,6-11H2,1H3,(H,26,30)

Chave InChI: LBFYQISQYCGDDW-UHFFFAOYSA-N

SMILES: CN1C=C(C=N1)C2=CC=C(C=C2)C3=CN=CC(=C3N4CCC5(CCNC5=O)CC4)Cl

CCT251545

CAS: 1661839-45-7

CCT251545 is an potent and oral-bioavailable WNT signaling inhibitor(IC50 of 5 nM in 7dF3 cells).

Fórmula: C₂₃H₂₄ClN₅O

Pureza: 98.29% - 98.69%

Cor e Forma: White Solid

Peso molecular: 421.923

Ref: TM-T14907

CCT251545

CAS: 1661839-45-7

CCT251545

Fórmula: C₂₃H₂₄ClN₅O

Pureza: ≥98%

Peso molecular: 421.92

Ref: 54-BUP04203

CCT251545

CAS: 1661839-45-7

Fórmula: C₂₃H₂₄ClN₅O

Pureza: %

Cor e Forma: Solid

Peso molecular: 421.9226

Ref: IN-DA001WJ4

CCT251545

CAS: 1661839-45-7

8-(3-Chloro-5-(4-(1-methyl-1H-pyrazol-4-yl)phenyl)pyridin-4-yl)-2,8-diazaspiro[4.5]decan-1-one

Fórmula: C₂₃H₂₄ClN₅O

Pureza: 98+%

Peso molecular: 421.92

Ref: IN-DG630423

2,8-Diazaspiro[4.5]decan-1-one, 8-[3-chloro-5-[4-(1-methyl-1H-pyrazol-4-yl)phenyl]-4-pyridinyl]-

CAS: 1661839-45-7

Pureza: 98+%

Peso molecular: 421.93

Ref: 10-F980115

CCT251545

CAS: 1661839-45-7

CCT251545 is a small molecule that inhibits the Wnt signaling pathway by binding to β-catenin. This drug may be used for the treatment of inflammatory bowel disease and other autoimmune diseases. The molecular structure of CCT251545 is still unknown but it has been shown to bind to the DNA binding proteins, which are important for gene expression. CCT251545 can also be used as a crystallography probe in X-ray crystallography experiments.

Fórmula: C₂₃H₂₄ClN₅O

Pureza: Min. 95%

Peso molecular: 421.92 g/mol

Ref: 3D-LRC83945